Cargando…

Molecular imaging of liver inflammation using an anti-VCAM-1 nanobody

To date, a biopsy is mandatory to evaluate parenchymal inflammation in the liver. Here, we evaluated whether molecular imaging of vascular cell adhesion molecule-1 (VCAM-1) could be used as an alternative non-invasive tool to detect liver inflammation in the setting of chronic liver disease. To do s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nachit, Maxime, Montemagno, Christopher, Clerc, Romain, Ahmadi, Mitra, Briand, François, Bacot, Sandrine, Devoogdt, Nick, Serdjebi, Cindy, Ghezzi, Catherine, Sulpice, Thierry, Broisat, Alexis, Leclercq, Isabelle A., Perret, Pascale
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9957989/ https://www.ncbi.nlm.nih.gov/pubmed/36828835 http://dx.doi.org/10.1038/s41467-023-36776-7

Ejemplares similares

In Vivo Assessment of VCAM-1 Expression by SPECT/CT Imaging in Mice Models of Human Triple Negative Breast Cancer
por: Montemagno, Christopher, et al.
Publicado: (2019)

In Vivo Biodistribution and Efficacy Evaluation of NeoB, A Radiotracer Targeted to GRPR, in Mice Bearing Gastrointestinal Stromal Tumor
por: Montemagno, Christopher, et al.
Publicado: (2021)

Biodistribution, Stability, and Blood Distribution of the Cell Penetrating Peptide Maurocalcine in Mice
por: Perret, Pascale, et al.
Publicado: (2015)

Direct Immobilization of Engineered Nanobodies on Gold Sensors
por: Simões, Bárbara, et al.
Publicado: (2021)

TrisOxine abiotic siderophores for technetium complexation: radiolabeling and biodistribution studies
por: Leenhardt, Julien, et al.
Publicado: (2023)

Enhanced Biosensor Platforms for Detecting the Atherosclerotic Biomarker VCAM1 Based on Bioconjugation with Uniformly Oriented VCAM1-Targeting Nanobodies
por: Ta, Duy Tien, et al.
Publicado: (2016)

From Malignant Progression to Therapeutic Targeting: Current Insights of Mesothelin in Pancreatic Ductal Adenocarcinoma
por: Montemagno, Christopher, et al.
Publicado: (2020)

Periaortic Brown Adipose Tissue as a Major Determinant of [(18)F]-Fluorodeoxyglucose Vascular Uptake in Atherosclerosis-Prone, ApoE(−/−) Mice
por: Toczek, Jakub, et al.
Publicado: (2014)

Mapping of brain tissue hematocrit in glioma and acute stroke using a dual autoradiography approach
por: Broisat, A., et al.
Publicado: (2018)

(99m)Tc-A1 as a Novel Imaging Agent Targeting Mesothelin-Expressing Pancreatic Ductal Adenocarcinoma
por: Montemagno, Christopher, et al.
Publicado: (2019)

Rationale of adding muscle volume to muscle fat infiltration in the definition of an adverse muscle composition is unclear
por: Nachit, Maxime, et al.
Publicado: (2021)

Nanobody-Facilitated Multiparametric PET/MRI Phenotyping of Atherosclerosis
por: Senders, Max L., et al.
Publicado: (2018)

Targeted Nanobody-Based Molecular Tracers for Nuclear Imaging and Image-Guided Surgery
por: Debie, Pieterjan, et al.
Publicado: (2019)

Nanobodies for the Early Detection of Ovarian Cancer
por: Tran, Lan-Huong, et al.
Publicado: (2022)

Immunogenicity Risk Profile of Nanobodies
por: Ackaert, Chloé, et al.
Publicado: (2021)

Radiolabeled nanobodies as theranostic tools in targeted radionuclide therapy of cancer
por: D’Huyvetter, Matthias, et al.
Publicado: (2014)

Theranostics in immuno-oncology using nanobody derivatives
por: Lecocq, Quentin, et al.
Publicado: (2019)

Development and Characterization of Nanobodies Targeting the Kupffer Cell
por: Zheng, Fang, et al.
Publicado: (2021)

Diet-induced obesity and NASH aggravate SARS-CoV-2 infection in golden Syrian hamsters
por: Briand, François, et al.
Publicado: (2022)

Identification of Nanobodies against the Acute Myeloid Leukemia Marker CD33
por: Romão, Ema, et al.
Publicado: (2020)

Impact of L-ornithine L-aspartate on non-alcoholic steatohepatitis-associated hyperammonemia and muscle alterations
por: Pichon, Camille, et al.
Publicado: (2022)

An enhanced level of VCAM in transplant preservation fluid is an independent predictor of early kidney allograft dysfunction
por: Baboudjian, Michael, et al.
Publicado: (2022)

Nanobody-based pannexin1 channel inhibitors reduce inflammation in acute liver injury
por: Van Campenhout, Raf, et al.
Publicado: (2023)

Targeted alpha therapy using short-lived alpha-particles and the promise of nanobodies as targeting vehicle
por: Dekempeneer, Yana, et al.
Publicado: (2016)

Therapeutic Nanobodies Targeting Cell Plasma Membrane Transport Proteins: A High-Risk/High-Gain Endeavor
por: Van Campenhout, Raf, et al.
Publicado: (2021)

Safety assessment of fluorescently labeled anti-EGFR Nanobodies in healthy dogs
por: do Valle, Nayra Cristina Herreira, et al.
Publicado: (2023)

Development and evaluation of nanobody tracers for noninvasive nuclear imaging of the immune-checkpoint TIGIT
por: Zeven, Katty, et al.
Publicado: (2023)

Targeted Radionuclide Therapy with A (177)Lu-labeled Anti-HER2 Nanobody
por: D'Huyvetter, Matthias, et al.
Publicado: (2014)

Recombinant expression of nanobodies and nanobody-derived immunoreagents
por: de Marco, Ario
Publicado: (2020)

Site-Specific Radiolabeling of a Human PD-L1 Nanobody via Maleimide–Cysteine Chemistry
por: Chigoho, Dora Mugoli, et al.
Publicado: (2021)

Specificity Evaluation and Disease Monitoring in Arthritis Imaging with Complement Receptor of the Ig superfamily targeting Nanobodies
por: Zheng, Fang, et al.
Publicado: (2016)

Noninvasive Imaging of the Immune Checkpoint LAG-3 Using Nanobodies, from Development to Pre-Clinical Use
por: Lecocq, Quentin, et al.
Publicado: (2019)

Myosteatosis rather than sarcopenia associates with non‐alcoholic steatohepatitis in non‐alcoholic fatty liver disease preclinical models
por: Nachit, Maxime, et al.
Publicado: (2020)

Antiproliferative activity, cell-cycle arrest, apoptotic induction and LC-HRMS/MS analyses of extracts from two Linum species
por: Mouna, Ryma, et al.
Publicado: (2022)

Improved Detection of Molecular Markers of Atherosclerotic Plaques Using Sub-Millimeter PET Imaging
por: Bridoux, Jessica, et al.
Publicado: (2020)

Non-invasive assessment of murine PD-L1 levels in syngeneic tumor models by nuclear imaging with nanobody tracers
por: Broos, Katrijn, et al.
Publicado: (2017)

The Design and Preclinical Evaluation of a Single-Label Bimodal Nanobody Tracer for Image-Guided Surgery
por: Debie, Pieterjan, et al.
Publicado: (2021)

Bile acids contribute to the development of non-alcoholic steatohepatitis in mice
por: Gillard, Justine, et al.
Publicado: (2021)

Imaging of Glioblastoma Tumor-Associated Myeloid Cells Using Nanobodies Targeting Signal Regulatory Protein Alpha
por: De Vlaminck, Karen, et al.
Publicado: (2021)

A 3‐week nonalcoholic steatohepatitis mouse model shows elafibranor benefits on hepatic inflammation and cell death
por: Briand, François, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_m6knmaqhc8spv13djc5emftd42